Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-label, Non-comparative Study

OBJECTIVES: To study the safety and efficacy of topical bevacizumab in the treatment of corneal neovascularization (NV). DESIGN: In a prospective, open-label, non-comparative study, 10 eyes from 10 patients with stable corneal NV were treated with topical bevacizumab 1.0% for 3 weeks and followed up...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dastjerdi, Mohammad H., Al-Arfaj, Khalid M., Nallasamy, Nambi, Hamrah, Pedram, Jurkunas, Ula V., Pineda, Roberto, Pavan-Langston, Deborah, Dana, Reza
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2703579/
https://ncbi.nlm.nih.gov/pubmed/19365012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archophthalmol.2009.18
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller